Package 50090-7711-0

{"route": ["ORAL"], "spl_id": "22c5edac-3f93-42d0-9542-03b5212dcac0", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["722650d8-5ee4-48ba-9827-7c86b1283522"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-0)", "package_ndc": "50090-7711-0", "marketing_start_date": "20251014"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-1)", "package_ndc": "50090-7711-1", "marketing_start_date": "20251014"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-2)", "package_ndc": "50090-7711-2", "marketing_start_date": "20251014"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50090-7711_22c5edac-3f93-42d0-9542-03b5212dcac0", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7711", "generic_name": "Bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20231025", "listing_expiration_date": "20261231"}